Form 4 for GH Guardant Health, Inc.
Accepted 2026-06-04 18:07:18 ET · period of report 2026-06-03 · accession 0001770749-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-06-04 18:07 | 2026-06-03 | GH | Joyce Meghan V. | Dir | M - OptEx | $38.05 | +10.0K | 21.2K | +89% | +$380.5K |
| DMT | 2026-06-04 18:07 | 2026-06-03 | GH | Joyce Meghan V. | Dir | S - Sale+OE | $126.98 | -10.0K | 11.2K | -47% | -$1.27M |
| DMT | 2026-06-04 18:07 | 2026-06-03 | GH | Joyce Meghan V. | Dir | M - OptEx | $0.00 | -10.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-03 | M | A | 1,197 | $38.42 | 12,380 | D | — | — | |
| 2 | Common | Common Stock | 2026-06-03 | M | A | 8,803 | $38.01 | 21,183 | D | — | — | |
| 3 | Common | Common Stock | 2026-06-03 | S | D | 3,516 | $126.52 | 17,667 | D | — | — | (F1) Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $125.80 to $126.785. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 4 | Common | Common Stock | 2026-06-03 | S | D | 5,728 | $127.11 | 11,939 | D | — | — | (F2) Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $126.815 to $127.75. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 5 | Common | Common Stock | 2026-06-03 | S | D | 650 | $128.02 | 11,289 | D | — | — | (F3) Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $127.92 to $128.24. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 6 | Common | Common Stock | 2026-06-03 | S | D | 106 | $129.31 | 11,183 | D | — | — | (F4) Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $129.28 to $129.83. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 7 | Derivative | Stock Option (Right to Buy) | 2026-06-03 | M | D | 1,197 | $0.00 | 7,908 | D | $38.42 · — to 2032-06-14 | 1,197 Common Stock | (F5) The stock option award vested in full on June 14, 2023. |
| 8 | Derivative | Stock Option (Right to Buy) | 2026-06-03 | M | D | 8,803 | $0.00 | 0 | D | $38.01 · — to 2033-06-14 | 8,803 Common Stock | (F6) The stock option award vested in full on June 12, 2024. |